{
    "relation": [
        [
            "",
            "STARTED",
            "COMPLETED",
            "NOT COMPLETED",
            "Adverse Event",
            "Lost to Follow-up",
            "Withdrawal by Subject",
            "Moved",
            "Unspecified",
            "Protocol Violation",
            "Uncooperative",
            "Subject Incarcerated"
        ],
        [
            "qHPV Vaccine in Base Study",
            "1822 [1]",
            "1487",
            "335",
            "3",
            "232",
            "53",
            "41",
            "2",
            "1",
            "3",
            "0"
        ],
        [
            "Placebo in Base Study",
            "1821 [2]",
            "1479",
            "342",
            "10",
            "226",
            "64",
            "36",
            "0",
            "0",
            "4",
            "2"
        ],
        [
            "EXT1: Placebo in Base Study",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        [
            "EXT1: Incomplete qHPV Regimen in Base Study",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ]
    ],
    "pageTitle": "An Investigational Study of Gardasil\u2122 (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00090285?sect=X0125&view=results",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 5,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990112.92/warc/CC-MAIN-20150728002310-00212-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 863253115,
    "recordOffset": 863235822,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Period 1: \u00a0 Base Study Vaccination Period Participant Flow for 3 periods Participants who received placebo and participants who received only 1 dose of qHPV vaccine in the base study were offered a complete 3-dose qHPV vaccine regimen (administered at EXT1 Day 1, Month 2 and Month 6). Participants who received only 2 doses of qHPV vaccine in the base study were offered a single additional dose of qHPV vaccine (administered at EXT1 Day 1). Participants were followed to EXT1 Month 7. EXT1: Incomplete qHPV Regimen in Base Study Participants in the placebo arm in the base study were offered 3 doses of open-label qHPV vaccine at EXT1 Day 1, Month 2 and Month 6. Participants were followed to EXT1 Month 7. EXT1: Placebo in Base Study The Vaccination Period for the base study encompassed Day 1 through Month 7, during which time participants received placebo at Day 1, Month 2 and Month 6. Follow-up for the base study encompassed Month 7 through Month 36. Placebo in Base Study The Vaccination Period for the base study encompassed Day 1 through Month 7, during which time participants received qHPV vaccination at Day 1, Month 2 and",
    "textAfterTable": "Site Terminated \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 Unspecified \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 Subject Incarcerated \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 HIV positive \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}